How Many Patients Are in Need of Vitamin B12 Injections?

Status Active, not recruiting

Clinical Trial Summary

The clinical consequences of vitamin B12 deficiency include megaloblastic anemia and neurological disorders. Therefore, a proper and timely diagnosis and treatment is important. The use of sensitive biochemical markers such as methylmalonic acid for the diagnosis of vitamin B12 deficiency have increased since the 1980s. Consequently, the number of individuals treated with vitamin B12 has increased significantly.

The objective of this project is to study the actual need for vitamin B12 injections in the group of individuals who have already started treatment. In order to investigate this, the investigators stop vitamin B12 treatment in this group, and look for signs of vitamin B12 deficiency by monitoring changes in biochemical and hematological markers. Furthermore, they will test if the individuals are able to absorb a physiological dose of vitamin B12 using a recently developed absorption test (CobaSorb). If a physiological dose can be absorbed, the vitamin B12 injections can be replaced with tablets. In the end, the investigators hope to be able to divide the patients into three groups:

1. need life long injections with vitamin B12,

2. only need supplementations with a small dose of oral vitamin B12, and

3. no need for further vitamin B12 treatment.

The perspective is that the new information from this study might be used for a future strategy for vitamin B12 treatment.

Clinical Trial Description

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00326833
Study type	Interventional
Source	University of Aarhus
Contact
Status	Active, not recruiting
Phase	Phase 4
Start date	January 2006
Completion date	December 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02270749` - Vitamin Deficiencies and Suppletion in Morbid Obesity	Phase 4
Completed	`NCT02540642` - Effect of Vitamin B12 Supplementation on Glycaemic Control in Uncontrolled Hyperhomocysteinemic Type 2 Diabetic Patients	N/A
Completed	`NCT00826657` - Vitamin B12 Supplementation Study	N/A
Completed	`NCT00843453` - Long-term Use of Proton Pump Inhibitors May Cause Vitamin B12 Deficiency in the Institutionalized Elderly	N/A
Completed	`NCT01584050` - Relative Bioavailability of Folic Acid and L-5-Methlytetrahydrofolate	N/A
Completed	`NCT01661309` - Supplementary Vitamin B12 Effects on Elevated Homocysteine Levels of Vegetarians - Clinical Trial	N/A
Completed	`NCT01876329` - Autoantibodies to Gastric Parietal Cells in Rheumatoid Arthritis Patients	N/A
Completed	`NCT01876732` - Impact of Vitamin B12 Replacement on Epogen Dosing and Improvement of Quality of Life in Hemodialysis Patients	N/A
Completed	`NCT00467623` - Holotranscobalamin Remains Unchanged During Pregnancy	N/A
Completed	`NCT02076347` - Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin	N/A
Completed	`NCT01297361` - The Association Between Religious Origin and Age, and Vitamin B12 and Folic Acid Plasma Levels in Non Jewish Population in Western Galilee	N/A
Completed	`NCT01136512` - Metformin Use and Vitamin B12 Deficiency	N/A
Active, not recruiting	`NCT04048330` - Periconceptional Surveillance in India
Completed	`NCT00699478` - Oral Vitamin B12 Administration for Vitamin B12 Deficiency After Total Gastrectomy	Phase 2
Completed	`NCT00279552` - Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.